Dance Biopharm is a private company focused on developing novel inhaled formulations of medicines to treat diabetes and other serious chronic diseases. The company began operations in 2010, founded by Dr. John Patton, who has more than 28 years of experience developing inhaled insulin and other inhaled therapies. For more information, please visit www.dancebiopharm.com
View Top Employees from Dance Biopharm| Website | http://www.dancebiopharm.com |
| Revenue | $13 million |
| Funding | $88.3 million |
| Employees | 11 (11 on RocketReach) |
| Founded | 2010 |
| Phone | (415) 769-4200 |
| Technologies | |
| Industry | Medical Devices & Equipment, Diabetes, Drug Delivery, Manufacturing, Health Care, Drug Discovery, Medical |
| Web Rank | 9 Million |
| Keywords | Dance Biopharm, Dance Biopharma, Dance Pharmaceuticals |
| Competitors | Diabeter, DreaMed, MannKind Corporation, TypeZero Technologies Inc., Valeritas |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular Dance Biopharm employee's phone or email?
Dance Biopharm Questions
The Dance Biopharm annual revenue was $13 million in 2023.
Anne Whitaker is the CEO of Dance Biopharm.
11 people are employed at Dance Biopharm.
Dance Biopharm is based in Brisbane, California.
The NAICS codes for Dance Biopharm are [54, 5417, 541].
The SIC codes for Dance Biopharm are [38, 384].
Top Dance Biopharm Employees
-
ViewLisa Spiess Yañez
Chief Executive Officer at Aerami Therapeutics at Dance Biopharm
Chapel Hill, North Carolina, United States21 -
5+2
-
15+
-
52
-
23
-
52
-
1
-
View
Joshua Ziel
Interim Chief Executive Officer; Chief Operating Officer at Dance Biopharm
New York, United States34
Related Companies
